Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Short Interest Update

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 7,300 shares, an increase of 102.8% from the February 28th total of 3,600 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 73.0 days.

Santhera Pharmaceuticals Trading Up 3.4 %

OTCMKTS:SPHDF traded up $0.56 during mid-day trading on Friday, hitting $17.01. 200 shares of the company’s stock traded hands, compared to its average volume of 333. The company has a fifty day moving average of $11.22 and a 200 day moving average of $11.03. Santhera Pharmaceuticals has a twelve month low of $16.00 and a twelve month high of $17.01.

Santhera Pharmaceuticals Company Profile

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).